Feedback / Questions
JJP-1212 - JJP Biologics
https://www.businesswire.com/news/home/20240528430176/en/JJP-Biologics-Announces-Positive-Decision-to-Execute-a-First-in-Human-Clinical-Trial-of-Anti-Inflammatory-mAb-JJP-1212-anti-CD89
May 29, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next